November 2019

BioAnalyt has developed a prototype device that measures red blood cells fragility as a screening tool for thalassemia in a low-resource setting. This prototype is referred to as iCheck Turbidity and is a portable nephelometer. There are ongoing tests regarding its robustness in the field. Preliminary results have been presented as an abstract in Singapore at “Indian Ocean Rim 2017 Laboratory Hematology Congress” and as a poster at the 2018 International Symposium on Technical Innovations in Laboratory Hematology in Belgium.


Related Stories

your story?

We want to feature you!